X4 Pharmaceuticals XFOR Q1 2026 Earnings Why the Beat Matters Goldman Sachs Warns UK TBills Not a Magic Bullet as Borrowing Costs Surge Graphic GPK Q1 2026 Earnings EPS 009 Beats Estimates